A blood antigen is a molecule sitting on the surface of your red blood cells that acts like an identity tag. Your immune system uses these tags to tell the difference between your own cells and foreign ones. If blood carrying unfamiliar antigens enters your body through a transfusion or pregnancy, your immune system can mount an attack against it. There are over 300 recognized red blood cell antigens, grouped into 30 blood group systems, though the ones you hear about most are ABO and Rh.
What Blood Antigens Are Made Of
Blood antigens come in two basic varieties: sugar-based and protein-based. The ABO, H, and Lewis blood group antigens are built from chains of sugar molecules attached to the outer surface of red blood cells. Your genes don’t build these sugar antigens directly. Instead, they produce enzymes that assemble the antigens one sugar unit at a time, like adding beads to a chain.
Most other blood group antigens, including Rh, Kell, Duffy, and Kidd, are proteins or glycoproteins (proteins with sugars attached). With these, the specific sequence of amino acids in the protein is what makes one person’s antigen different from another’s. This distinction matters medically because sugar-based and protein-based antigens trigger different types of immune responses. Sugar antigens tend to provoke a quick, short-lived antibody reaction, while protein antigens trigger a response that builds over time and produces longer-lasting antibodies.
The ABO System
The ABO system is the most familiar set of blood antigens and the one that matters most in transfusion. It works like a building project. Every person starts with a foundation structure called the H antigen, a core of 5 to 13 sugars ending in a sugar called fucose. What happens next depends on your genes.
If you have the gene for blood type A, it produces an enzyme that sticks one more sugar, N-acetylgalactosamine, onto the H antigen. If you have the gene for type B, a slightly different enzyme adds galactose instead. People with type AB have both enzymes working, so their red blood cells carry both A and B antigens. People with type O have neither functional enzyme, so their cells display only the unmodified H antigen with nothing extra added.
Your body naturally produces antibodies against whichever ABO antigens you lack. Someone with type A blood has anti-B antibodies circulating in their plasma from early childhood, even without ever being exposed to type B blood. This is why ABO compatibility is the first thing checked before a transfusion: giving type A blood to a type B person would trigger an immediate immune attack that destroys the transfused red blood cells.
The Rh Factor
The second most important blood antigen is the D antigen in the Rh system. This is what the “positive” or “negative” in your blood type refers to. Unlike ABO antigens, the D antigen is a protein woven through the red blood cell membrane, looping back and forth across it 12 times.
The D antigen is exceptionally good at provoking an immune response. About 80% of Rh-negative people will develop antibodies after receiving just 200 mL of Rh-positive blood. For this reason, every blood donor and transfusion recipient is routinely typed for the D antigen so that Rh-negative patients receive Rh-negative blood.
Some people carry a weakened or partial version of the D antigen on their cells. Handling this gets a bit nuanced: if such a person donates blood, their donation is labeled Rh-positive (to protect Rh-negative recipients). But if that same person needs a transfusion, they’re treated as Rh-negative and given Rh-negative blood, since their immune system could still react against a full-strength D antigen.
How Blood Antigens Are Inherited
You inherit your blood antigens from your parents, much like eye color. For the ABO system, you get one allele from each parent. The A and B alleles are co-dominant (both express if present), while O is recessive (it only shows up when you inherit it from both parents). Someone with type A blood might carry two A alleles or one A and one O. Someone with type AB always carries one A and one B.
Combined with the Rh factor, this inheritance pattern produces the eight common blood types. In the UK donor population, O positive is the most common at 36%, followed by A positive at 28%. The rarest common type is AB negative at about 1%. Distributions shift significantly across ethnic groups and geographies, which is one reason blood banks actively recruit diverse donors.
Beyond ABO and Rh
The International Society of Blood Transfusion recognizes nine major blood group systems, and most people never need to think about the ones beyond ABO and Rh. But for people who receive repeated transfusions, such as those with sickle cell disease or certain cancers, these minor systems become important because the immune system can gradually develop antibodies against unfamiliar antigens in any of them.
The Kidd system is a good example of why these matter. Kidd antibodies are notorious for causing delayed transfusion reactions. They can fade to undetectable levels in a person’s blood, then surge back rapidly if they encounter Kidd-incompatible blood again. This makes them easy to miss on routine screening and dangerous on repeat transfusions. The Kell, Duffy, and MNS systems each carry their own clinical quirks that transfusion specialists track carefully for patients with complex transfusion histories.
Antigens Do More Than Identify Blood
Blood antigens aren’t just passive identity markers. Many of the proteins that carry them have day jobs in the body. The protein carrying Kidd antigens functions as a urea transporter, moving waste products across cell membranes in both red blood cells and the kidneys. Rh proteins are thought to serve as ammonia transporters. The Kell protein processes a signaling molecule involved in blood vessel regulation. Others function as enzymes, adhesion molecules, or water channels.
This dual role means that in rare cases where a person completely lacks a particular blood group protein, they can experience health effects beyond just transfusion incompatibility. The antigen is just one feature of a molecule that the body relies on for other purposes.
Rh Disease in Pregnancy
One of the most significant clinical consequences of blood antigens occurs when an Rh-negative mother carries an Rh-positive baby. During pregnancy, small amounts of fetal blood routinely cross into the mother’s circulation. This happens in roughly 75% of all pregnancies. If the fetal red blood cells carry the D antigen and the mother’s don’t, her immune system may recognize them as foreign and begin producing antibodies.
The first pregnancy is usually fine because the initial immune response is slow and relatively weak. The danger comes in subsequent pregnancies with another Rh-positive baby. By then, the mother’s immune system has a memory of the D antigen and can mount a rapid, powerful response with as little as 0.03 mL of fetal blood crossing over. Her antibodies cross the placenta, attach to the baby’s red blood cells, and mark them for destruction, primarily in the baby’s spleen. This condition, called hemolytic disease of the newborn, can range from mild anemia to life-threatening complications.
The risk after a first Rh-incompatible pregnancy is about 16% if mother and baby are ABO-compatible, dropping to around 2% if they’re ABO-incompatible. That drop happens because ABO-incompatible fetal cells are destroyed quickly in the mother’s bloodstream before her immune system has time to learn the Rh antigen. Modern prevention involves giving Rh-negative mothers an injection of anti-D antibodies during and after pregnancy, which clears fetal red blood cells before the mother’s immune system reacts to them.
Blood Antigens and Malaria
The global distribution of blood types isn’t random. It has been shaped by thousands of years of infectious disease, particularly malaria. Blood type O appears to offer a survival advantage against severe malaria caused by the parasite P. falciparum. The parasite causes infected red blood cells to stick to uninfected ones, forming clumps called rosettes. These rosettes form more easily and grow larger on cells carrying A or B antigens compared to type O cells, which lack those extra sugars.
The clinical data is striking. In a study from Sri Lanka, type O made up 48% of mild malaria cases but only 24% of severe ones. Type A showed the opposite pattern: 25% of mild cases but 33% of severe ones. In Zimbabwe, coma was three times more common among type A patients with malaria compared to non-A patients. This survival pressure helps explain why type O is the most common blood type worldwide and is especially prevalent in regions with historically high malaria rates. The Duffy blood group tells a similar story: the Duffy-negative phenotype, which is extremely common in people of African descent, prevents the malaria parasite P. vivax from entering red blood cells entirely.